RE:Shoppers/Maple/MDXI would be suprised if MedX wasn't having discussions with all the major teleheath companies and pharmacies because they cannot assess pigmented lesions. This would be a perfect fit. I am sure we will continue to hear more developments in Q1 as they promised.